Patient Guide: This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 99 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT07028853
Status: 🟢 Enrolling Now
Condition: Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate
Phase: PHASE3

Find a Study Location Near You

This study is available at 99 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Chandler, Arizona
  • Gilbert, Arizona
  • Glendale, Arizona
  • • And 96 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily